MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Therapeutic effects of PNF techniques versus standard physiotherapy exercise on diaphragmatic muscle activity in in the treatment young onsets of Parkinsons survivors

    T. Karthikeyan (Gurugram, India)

    Objective: To find out the Therapeutic effects of PNF techniques versus standard physiotherapy exercise on diaphragmatic muscle activity in in the treatment young onsets of…
  • 2024 International Congress

    A telehealth physical activity coaching program can maintain physical activity and exercise confidence in people with Parkison disease: a cohort study.

    D. Wani, A. Chandrana, A. Pacheco, D. Kipnis, J. Alomar, C. Macpherson, J. Fineman, L. Quinn (New York, USA)

    Objective: To examine the efficacy of the Engage-PD program in sustaining physical activity gains in people with Parkison disease. Background: Parkinson disease (PD) is a…
  • 2024 International Congress

    Acute effects of a multicomponent aquatic training session on heart rate variability in PD: a case study

    A. Doliny, S. Souza, J. Siega, V. Israel (CURITIBA, Brazil)

    Objective: To analyze the acute effects of a multicompartment aquatic training (MAT) session on heart rate variability (HRV) in a person with Parkinson's disease (PD).…
  • 2024 International Congress

    Could Augmented Reality With Biofeedback Be Beneficial In Improvement Of Motor And Non-motor Symptoms In Patients With Parkinson’s Disease?

    P. Lisewski, B. Lisewska, M. Wasilewska, W. Fronskiewicz (Bydgoszcz, Poland)

    Objective: The assessment of the biofeedback and AR training effects in patients with Parkinson's disease (PD) is worth exploring. Background: Parkinson disease (PD) is a…
  • 2024 International Congress

    Gender Disparities in Quality of Life Domains Among Hispanic Individuals with Parkinson’s Disease: A Comparative Analysis

    D. Bustamante-Mieles, C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: This study aims to determine gender differences in the quality of life of Parkinson's disease (PD) among Hispanic individuals. Background: PD profoundly affects various…
  • 2024 International Congress

    Deep Brain Stimulation From the Perspective of Relatives and Caregivers: A Qualitative Analysis and Caregiver Burden

    TUC. Saltoglu, YSK. Sücüllü Karadağ (İNCEK, Turkey)

    Objective: One of the most important conditions for success in Deep brain stimulation (DBS), which has been proven effective for more than thirty years and…
  • 2024 International Congress

    Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation

    J. Verbrugge, H. Oas, L. Cook, T. Schwantes-An, L. Walsh, T. Foroud, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, A. Hall, A. Naito, J. Beck, R. Alcalay (Indianapolis, USA)

    Objective: To investigate whether participants in the PD GENEration study (NCT04994015) perceived personal benefit from receiving genetic testing for Parkinson’s disease (PD), whether being tested…
  • 2024 International Congress

    ORION: A Global Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of AMX0035 in Progressive Supranuclear Palsy (A35-009)

    A-M. Wills, G. Höglinger, L. Mehta, M. Leinders, Y. Wu, J. Timmons, A. Hayden, I. Aiba, A. Antonini, A. Boxer, Y. Compta, J-C. Corvol, A. Lang, H. Morris, P. Svenningsson, H. [email protected], L. Golbe (Boston, USA)

    Objective: Here we describe ORION, a phase 3 trial assessing efficacy and safety of AMX0035 in progressive supranuclear palsy (PSP). Background: PSP is a rare,…
  • 2024 International Congress

    Sleep disorders in Parkinson’s disease

    M. Mirqosimova (Dushanbe, Tajikistan)

    Objective: to specify the clinical features of sleep disorders in patients with PD and their impact on quality of life indicators; assessment of the relationship…
  • 2024 International Congress

    Assembling a Cohort of Hyposmic Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention

    B. Mcmahon, L. Lemon, R. Dobkin, E. Brown, J. Dimos, M. Kuhl, L. Heathers (Baltimore, USA)

    Objective: The goal of this project was to amass a cohort of individuals with hyposmia to later invite them to participate in clinical trials for…
  • « Previous Page
  • 1
  • …
  • 171
  • 172
  • 173
  • 174
  • 175
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley